US FDA's FY 2023 User Fees Finally Revealed

 
• By Derrick Gingery

Several fees for prescription drug, generic drug, and biosimilar applications are set to increase, although some also will drop.

Fees
The new user fees were announced five days into FY 2023 after Congress did not renew the programs until 30 September. • Source: Shutterstock

More from User Fees

More from Pathways & Standards